Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 10, 2022

SELL
$20.95 - $26.88 $1.89 Million - $2.42 Million
-90,199 Closed
0 $0
Q3 2021

Nov 10, 2021

BUY
$17.26 - $27.08 $365,963 - $574,177
21,203 Added 30.73%
90,199 $2.3 Million
Q2 2021

Aug 13, 2021

BUY
$17.76 - $24.83 $10,496 - $14,674
591 Added 0.86%
68,996 $1.45 Million
Q1 2021

May 13, 2021

SELL
$13.48 - $23.77 $109,255 - $192,655
-8,105 Reduced 10.59%
68,405 $1.61 Million
Q4 2020

Feb 12, 2021

BUY
$12.17 - $17.52 $568,679 - $818,674
46,728 Added 156.9%
76,510 $1.07 Million
Q3 2020

Nov 12, 2020

BUY
$11.22 - $14.46 $334,154 - $430,647
29,782 New
29,782 $374,000

Others Institutions Holding IDYA

About IDEAYA Biosciences, Inc.


  • Ticker IDYA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,067,700
  • Market Cap $1.31B
  • Description
  • IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinica...
More about IDYA
Track This Portfolio

Track Massachusetts Financial Services CO Portfolio

Follow Massachusetts Financial Services CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Massachusetts Financial Services CO , based on Form 13F filings with the SEC.

News

Stay updated on Massachusetts Financial Services CO with notifications on news.